Category Archives: Genetic Therapy

BEYOND THERAPY: BIOTECHNOLOGY AND THE PURSUIT OF HAPPINESS biotech.law.lsu.edu GENE TOOLS, LLC http://www.gene-tools.com DISTRESS OF HAIR LOSS The feasibility of targeted selective gene therapy of the hair follicle. http://www.ncbi.nlm.nih.gov TISSUE ENGINEERING IN PERSPECTIVE- Eugene Bell http://www.chemeng.queensu.ca THE HAIR FOLLICLE AND ITS STEM CELLS AS DRUG DELIVERY TARGETS http://www.metamouse.com Supramolecular Biomaterials. A Modular Approach towards Tissue Engineering http://www.csj.jp STEM CELL RESEARCH ec.europa.eu Liposomes for Use in Gene Delivery tulane.edu DYNAMIC CONSTITUTIONAL MATERIALS.

Continued here:
THE NEW MORGELLONS HAIR - Video

There has been much excitement over the announcements of results of the Gene Therapy trials conducted by Dr Robin Ali (fast becoming a hero in my world!). The trial is for a treatment for LCA, Leber's Congenital Amaurosis, a rare form of a Retinal Disease / Retinitis Pigmentosa and has produced some amazing results

Read the rest here:
First results of Gene Therapy Trials by Professor Robin Ali - Video

Dr.

More:
Promising gene therapy treats Leukemia - Video

Gene therapy is a technique that has promised much, but has yet to really deliver. The field got off to a good start in 1990 when Dr French Anderson successfully used retroviral delivery to overcome adenosine deaminase deficiency (ADA) in 4 yr old Ashanti de Silva.

Originally posted here:
Gene Therapy - Video

Gene Therapy Reveals Unexpected Immunity in Duchenne Muscular Dystrophy

Continue reading here:
Gene Therapy Reveals Unexpected Immunity - Video

Air date: Wednesday, December 15, 2010, 3:00:00 PM Timedisplayed is Eastern Time, Washington DC Local Category: Wednesday Afternoon Lectures Description: Gene therapy has the potential to reverse disease or prevent further deterioration of vision in patients with incurable inherited retinal degeneration. The demonstration of safe and stable recovery of retinal/visual function in 12 children and adults with Leber congenital amaurosis (LCA) due to RPE65 mutations in a trial being carried out at The Children's Hospital of Philadelphia (CHOP), and encouraging results from four other clinical trials for LCA-RPE65 provide great hope for people with other more common blinding diseases.

More here:
Seeing is Believing: A Gene Therapy Success - Video